While the effects of the pandemic on businesses are starting to ease, some companies made great leaps forward over the last couple of years. One of these is hVivo (formerly

New analysis shows how the SARS-CoV-2 virus spreads from the nose to the air and surfaces in the immediate surroundings. The findings are the second batch of results to come from

What is a human challenge study? In a human challenge study, healthy volunteers are intentionally infected with a virus/bacteria or parasite in a quarantine facility. The volunteers are monitored under 24/7 supervision

As a medicinal expert at one of the leading notified bodies of the EU, I’ve been involved in the assessment of medicinal files of many different device-drug combination products. These

What can deliberately infecting healthy people tell us about infectious diseases? How is this useful for developing treatments, and how do we manage the risks? hVIVO plc (formerly Open Orphan plc)

The European Mediscience Awards is now in its 21st year, having been held every year since inception in 2002. The event is the largest annual gathering of private and publicly quoted

Committee (HREC) to initiate a Phase I trial of CDI-988 for the treatment of Covid-19. CDI-988 is an oral, broad-spectrum 3CL protease inhibitor designed using Cocrystal’s proprietary drug discovery platform technology. The

Introducing Dr Catchpole As Chief Scientific Officer, Dr Catchpole has “overall responsibility for the scientific conduct” of hVIVO’s studies and laboratory services, and oversees the manufacturing of their challenge viruses.

hVIVO plc (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge

IntroductionA small sized pharmaceutical company, who had already performed proof-of-concept studies with a small molecule drug candidate came to Venn Life Sciences with the aim to bring their product into